                         SEQUENCE LISTING

<110>  Cardio3 Biosciences S.A.
 
<120>  Therapeutic targets and agents useful in treating ischemia 
       reperfusion injury

<130>  C3B-001-PCT

<150>  EP13197532.8
<151>  2013-12-16

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  76
<212>  PRT
<213>  artificial sequence

<220>
<223>  fragment of antibody


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or 
       H, preferably G, A, V, L, P, F, M, W, C, N, Q, S, T, Y, D, E, K, 
       R or H

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or H

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or H

<220>
<221>  MISC_FEATURE
<222>  (22)..(22)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or H

<220>
<221>  MISC_FEATURE
<222>  (53)..(53)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or H

<400>  1

Phe Ser Xaa Ser Arg Tyr Ser Val Tyr Trp Xaa Arg Gln Pro Pro Gly 
1               5                   10                  15      


Lys Gly Xaa Glu Trp Xaa Gly Met Met Trp Gly Gly Gly Ser Thr Asp 
            20                  25                  30          


Tyr Ser Thr Ser Leu Lys Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser 
        35                  40                  45              


Lys Ser Gln Val Xaa Leu Lys Met Asn Ser Leu Arg Thr Asp Asp Thr 
    50                  55                  60                  


Ala Met Tyr Tyr Cys Val Arg Thr Asp Gly Asp Tyr 
65                  70                  75      


<210>  2
<211>  113
<212>  PRT
<213>  artificial sequence

<220>
<223>  fragment of antibody


<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or 
       H, preferably G, A, V, L, P, F, M, W, C, N, Q, S, T, Y, D, E, K, 
       R or H

<220>
<221>  MISC_FEATURE
<222>  (37)..(37)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or H

<220>
<221>  MISC_FEATURE
<222>  (45)..(45)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or H

<220>
<221>  MISC_FEATURE
<222>  (48)..(48)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or H

<220>
<221>  MISC_FEATURE
<222>  (79)..(79)
<223>  X is G, A, V, L, I, P, F, M, W, C, N, Q, S, T, Y, D, E, K, R or H

<400>  2

Gln Val Lys Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Ile Thr Cys Thr Val Ser Gly Phe Ser Xaa Ser Arg Tyr 
            20                  25                  30          


Ser Val Tyr Trp Xaa Arg Gln Pro Pro Gly Lys Gly Xaa Glu Trp Xaa 
        35                  40                  45              


Gly Met Met Trp Gly Gly Gly Ser Thr Asp Tyr Ser Thr Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Ser Gln Val Xaa Leu 
65                  70                  75                  80  


Lys Met Asn Ser Leu Arg Thr Asp Asp Thr Ala Met Tyr Tyr Cys Val 
                85                  90                  95      


Arg Thr Asp Gly Asp Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
            100                 105                 110         


Ser 
    


<210>  3
<211>  89
<212>  PRT
<213>  fragment of antibody


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is N, Q, S, T, Y, W or C

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is D, E, N, Q, S, T, Y, W or C

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is N, Q, S, T, Y, G, A, V, L, I, P, F, M, W or C

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is G, A, V, L, I, P, F, M

<220>
<221>  MISC_FEATURE
<222>  (75)..(75)
<223>  X is G, A, V, L, I, P, F, M

<220>
<221>  MISC_FEATURE
<222>  (79)..(79)
<223>  X is N, Q, S, T, Y, G, A, V, L, I, P, F, M, W or C

<400>  3

Xaa Leu Gly Xaa Xaa Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu 
1               5                   10                  15      


Xaa Asn Ser Asn Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Arg Pro 
            20                  25                  30          


Gly Gln Ser Pro Arg Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser 
        35                  40                  45              


Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
    50                  55                  60                  


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Xaa Gly Val Tyr Xaa Cys 
65                  70                  75                  80  


Ser Gln Ser Thr His Val Pro Trp Thr 
                85                  


<210>  4
<211>  113
<212>  PRT
<213>  fragment of antibody


<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is N, Q, S, T, Y, W or C

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  X is D, E, N, Q, S, T, Y, W or C

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  X is N, Q, S, T, Y, G, A, V, L, I, P, F, M, W or C

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  X is G, A, V, L, I, P, F, M

<220>
<221>  MISC_FEATURE
<222>  (88)..(88)
<223>  X is G, A, V, L, I, P, F, M

<220>
<221>  MISC_FEATURE
<222>  (92)..(92)
<223>  X is N, Q, S, T, Y, G, A, V, L, I, P, F, M, W or C

<400>  4

Glu Leu Gln Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Xaa Leu Gly 
1               5                   10                  15      


Xaa Xaa Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Xaa Asn Ser 
            20                  25                  30          


Asn Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Xaa Gly Val Tyr Xaa Cys Ser Gln Ser 
                85                  90                  95      


Thr His Val Pro Trp Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg 
    


